FDA Drug Recalls

Recalls / Class III

Class IIID-0595-2024

Product

Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1725-01 (vial), NDC 70710-1725-06 (outer box).

Affected lot / code info
Lot #: L300220, Exp. 05/31/2025.

Why it was recalled

Cross contamination with other products

Recalling firm

Firm
Zydus Pharmaceuticals (USA) Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
73 Route 31 N, N/A, Pennington, New Jersey 08534-3601

Distribution

Quantity
12720 vials
Distribution pattern
Nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2024-07-02
FDA classified
2024-07-10
Posted by FDA
2024-07-17
Status
Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0595-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.